These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11793621)

  • 1. Aggravation of glaucoma with fluvoxamine.
    Jiménez-Jiménez FJ; Ortí-Pareja M; Zurdo JM
    Ann Pharmacother; 2001 Dec; 35(12):1565-6. PubMed ID: 11793621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late bilateral acute angle-closure glaucoma after administration of paroxetine in a patient with plateau iris configuration.
    Levy J; Tessler Z; Klemperer I; Shneck M; Lifshitz T
    Can J Ophthalmol; 2004 Dec; 39(7):780-1. PubMed ID: 15696770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Not Available].
    Povlsen K; Skov K; Kolko M; Bach-Holm D; Andersen SE
    Ugeskr Laeger; 2023 Nov; 185(48):. PubMed ID: 38018726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram-induced uveal effusions and bilateral angle closure glaucoma.
    Zelefsky JR; Fine HF; Rubinstein VJ; Hsu IS; Finger PT
    Am J Ophthalmol; 2006 Jun; 141(6):1144-7. PubMed ID: 16765693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
    Kohn Y; Weizman A; Apter A
    Int J Eat Disord; 2001 Jul; 30(1):113-7. PubMed ID: 11439417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral acute angle closure glaucoma after administration of paroxetine.
    Kirwan JF; Subak-Sharpe I; Teimory M
    Br J Ophthalmol; 1997 Mar; 81(3):252. PubMed ID: 9135392
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute angle closure glaucoma after sertraline.
    Ho HY; Kam KW; Young AL; Chan LK; Yu EC
    Gen Hosp Psychiatry; 2013; 35(5):575.e1-2. PubMed ID: 23040863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine-induced acute angle closure.
    Kahraman N; Durmaz O; Durna MM
    Indian J Ophthalmol; 2015 Jun; 63(6):539-40. PubMed ID: 26265648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restlessness related to SSRI withdrawal.
    Hirose S
    Psychiatry Clin Neurosci; 2001 Feb; 55(1):79-80. PubMed ID: 11235863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased libido in a woman treated with fluvoxamine: a case report.
    Hori H; Yoshimura R; Nakamura J
    Acta Psychiatr Scand; 2001 Apr; 103(4):312-4. PubMed ID: 11328247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of peripheral serotonin 5-HT3 receptors in fluvoxamine-induced emesis in Suncus murinus.
    Fujiwara-Sawada M; Imanishi T; Yoshida A; Baba J
    J Pharm Pharmacol; 2003 Feb; 55(2):271-4. PubMed ID: 12631420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome and fluvoxamine: a case study.
    Bastani JB; Troester MM; Bastani AJ
    Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Montejo-González AL; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Ciudad J; Daniel E; De la Gandara J; Derecho J; Franco M; Gomez MJ; Macias JA; Martin T; Perez V; Sanchez JM; Sanchez S; Vicens E
    J Sex Marital Ther; 1997; 23(3):176-94. PubMed ID: 9292833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin syndrome induced by fluvoxamine and oxycodone.
    Karunatilake H; Buckley NA
    Ann Pharmacother; 2006 Jan; 40(1):155-7. PubMed ID: 16368927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed recurrent SIADH associated with SSRIs.
    Arinzon ZH; Lehman YA; Fidelman ZG; Krasnyansky II
    Ann Pharmacother; 2002; 36(7-8):1175-7. PubMed ID: 12086550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of dry mouth by replacing paroxetine with fluvoxamine.
    Arima Y; Kubo C; Tsujimoto M; Ohtani H; Sawada Y
    Ann Pharmacother; 2005 Mar; 39(3):567-71. PubMed ID: 15701774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H; Bergsholm YK; Bøhler E; Spigset O
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin syndrome induced by fluvoxamine and mirtazapine.
    Demers JC; Malone M
    Ann Pharmacother; 2001 Oct; 35(10):1217-20. PubMed ID: 11675850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.